- Home
- LFWD vs NEPH Comparison
LFWD vs NEPH Comparison
Compare LFWD & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- NEPH
- Stock Information
- Founded
- LFWD 2001
- NEPH 1997
- Country
- LFWD Israel
- NEPH United States
- Employees
- LFWD N/A
- NEPH N/A
- Industry
- LFWD
- NEPH Medical/Dental Instruments
- Sector
- LFWD
- NEPH Health Care
- Exchange
- LFWD NYSE
- NEPH Nasdaq
- Market Cap
- LFWD 18.6M
- NEPH 16.8M
- IPO Year
- LFWD 2014
- NEPH 2004
- Fundamental
- Price
- LFWD $1.60
- NEPH $2.13
- Analyst Decision
- LFWD Strong Buy
- NEPH Buy
- Analyst Count
- LFWD 3
- NEPH 1
- Target Price
- LFWD $9.00
- NEPH $5.00
- AVG Volume (30 Days)
- LFWD 5.6M
- NEPH 12.4K
- Earning Date
- LFWD 05-14-2025
- NEPH 05-08-2025
- Dividend Yield
- LFWD N/A
- NEPH N/A
- EPS Growth
- LFWD N/A
- NEPH N/A
- EPS
- LFWD N/A
- NEPH 0.01
- Revenue
- LFWD $25,663,000.00
- NEPH $14,162,000.00
- Revenue This Year
- LFWD $16.16
- NEPH $9.23
- Revenue Next Year
- LFWD $51.10
- NEPH $12.99
- P/E Ratio
- LFWD N/A
- NEPH $298.53
- Revenue Growth
- LFWD 85.24
- NEPH N/A
- 52 Week Low
- LFWD $1.25
- NEPH $1.36
- 52 Week High
- LFWD $6.00
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- LFWD 45.36
- NEPH 78.82
- Support Level
- LFWD $1.71
- NEPH $1.55
- Resistance Level
- LFWD $1.82
- NEPH $1.62
- Average True Range (ATR)
- LFWD 0.14
- NEPH 0.10
- MACD
- LFWD -0.01
- NEPH 0.06
- Stochastic Oscillator
- LFWD 27.27
- NEPH 87.79
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.